For compounding pharmacies or physicians that have been compounding semaglutide products during the shortage, the FDA has set clear deadlines for ceasing general semaglutide compounding practices: State-licensed pharmacies or physicians compounding semaglutide under Section 503A of the FD&C Act must stop compounding, distributing, or dispensing semaglutide injections that are essentially copies of an FDA-approved product by April 22, 2025
Store multi-dose vials or single-patient use KwikPens in the refrigerator between 36F and 46F (2C and 8C) or at room temperature (up to 86F [30C])
Another patient was so horrified after suffering hair loss she said that she would rather be 'fat and able to hide behind my hair than skinny with bald spots'
Preliminary animal studies suggest allulose may stimulate GLP-1 secretion, but robust human evidence is lacking
That last one surprises people
By prescribing phentermine and topiramate individually, patients may achieve similar or even better outcomes at a significantly lower cost